These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36318270)

  • 21. The vesicular monoamine transporter 2: an underexplored pharmacological target.
    Bernstein AI; Stout KA; Miller GW
    Neurochem Int; 2014 Jul; 73():89-97. PubMed ID: 24398404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Large-scale evaluation of SLC18A2 in prostate cancer reveals diagnostic and prognostic biomarker potential at three molecular levels.
    Haldrup C; Lynnerup AS; Storebjerg TM; Vang S; Wild P; Visakorpi T; Arsov C; Schulz WA; Lindberg J; Grönberg H; Egevad L; Borre M; Ørntoft TF; Høyer S; Sørensen KD
    Mol Oncol; 2016 Jun; 10(6):825-37. PubMed ID: 26905753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic variants in the vesicular monoamine transporter 1 (VMAT1/SLC18A1) and neuropsychiatric disorders.
    Lohoff FW
    Methods Mol Biol; 2010; 637():165-80. PubMed ID: 20419435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo.
    Lohr KM; Bernstein AI; Stout KA; Dunn AR; Lazo CR; Alter SP; Wang M; Li Y; Fan X; Hess EJ; Yi H; Vecchio LM; Goldstein DS; Guillot TS; Salahpour A; Miller GW
    Proc Natl Acad Sci U S A; 2014 Jul; 111(27):9977-82. PubMed ID: 24979780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic analysis of P387L mutation in SLC18A2 gene in sporadic Parkinson's disease in Chinese Han population.
    Kang J; Tang B; Li K; Liu Z; Yan X; Guo J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 40(8):825-8. PubMed ID: 26333488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cat-1 gene of Caenorhabditis elegans encodes a vesicular monoamine transporter required for specific monoamine-dependent behaviors.
    Duerr JS; Frisby DL; Gaskin J; Duke A; Asermely K; Huddleston D; Eiden LE; Rand JB
    J Neurosci; 1999 Jan; 19(1):72-84. PubMed ID: 9870940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic and epigenetic SLC18A2 silencing in prostate cancer is an independent adverse predictor of biochemical recurrence after radical prostatectomy.
    Sørensen KD; Wild PJ; Mortezavi A; Adolf K; Tørring N; Heebøll S; Ulhøi BP; Ottosen P; Sulser T; Hermanns T; Moch H; Borre M; Ørntoft TF; Dyrskjøt L
    Clin Cancer Res; 2009 Feb; 15(4):1400-10. PubMed ID: 19228741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parkinsonism-dystonia-2: Case-series study from Saudi Arabia.
    Almuqbil MA; Tabassum S; Muthaffar OY; Ghamdi F; Al Masseri Z; Alsaman A; Alkhater RA
    Ann Clin Transl Neurol; 2024 Apr; 11(4):1063-1066. PubMed ID: 38389300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunochemical localization of vesicular monoamine transporter 2 (VMAT2) in mouse brain.
    Cliburn RA; Dunn AR; Stout KA; Hoffman CA; Lohr KM; Bernstein AI; Winokur EJ; Burkett J; Schmitz Y; Caudle WM; Miller GW
    J Chem Neuroanat; 2017 Oct; 83-84():82-90. PubMed ID: 27836486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SLC18A2 promoter haplotypes and identification of a novel protective factor against alcoholism.
    Lin Z; Walther D; Yu XY; Li S; Drgon T; Uhl GR
    Hum Mol Genet; 2005 May; 14(10):1393-404. PubMed ID: 15829504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Involvement of vesicular monoamine transporter in attention deficit hyperactivity disorder].
    Lorenzo-Sanz G; Sánchez-Herranz A
    Rev Neurol; 2011 Mar; 52 Suppl 1():S103-8. PubMed ID: 21365590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) function in knockout mice affects aging of dopaminergic systems.
    Hall FS; Itokawa K; Schmitt A; Moessner R; Sora I; Lesch KP; Uhl GR
    Neuropharmacology; 2014 Jan; 76 Pt A(0 0):146-55. PubMed ID: 23978383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intermediate phenotype analysis of patients, unaffected siblings, and healthy controls identifies VMAT2 as a candidate gene for psychotic disorder and neurocognition.
    Simons CJ; van Winkel R;
    Schizophr Bull; 2013 Jul; 39(4):848-56. PubMed ID: 22532702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biallelic SHQ1 variants in early infantile hypotonia and paroxysmal dystonia as the leading manifestation.
    Chi CS; Tsai CR; Lee HF
    Hum Genet; 2023 Aug; 142(8):1029-1041. PubMed ID: 36847845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High regulatability favors genetic selection in SLC18A2, a vesicular monoamine transporter essential for life.
    Lin Z; Zhao Y; Chung CY; Zhou Y; Xiong N; Glatt CE; Isacson O
    FASEB J; 2010 Jul; 24(7):2191-200. PubMed ID: 20181938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered expression of vesicular monoamine transporter 2 in epileptic patients and experimental rats.
    Jiang G; Cao Q; Li J; Zhang Y; Liu X; Wang Z; Guo F; Chen Y; Chen Y; Chen G; Wang X
    Synapse; 2013 Jul; 67(7):415-26. PubMed ID: 23504951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration.
    Caudle WM; Richardson JR; Wang MZ; Taylor TN; Guillot TS; McCormack AL; Colebrooke RE; Di Monte DA; Emson PC; Miller GW
    J Neurosci; 2007 Jul; 27(30):8138-48. PubMed ID: 17652604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VMAT2 gene (
    Randesi M; van den Brink W; Levran O; Blanken P; van Ree JM; Ott J; Kreek MJ
    Pharmacogenomics; 2019 Apr; 20(5):331-341. PubMed ID: 30983500
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of vesicular monoamine transporter type 2 in rodent insulin secretion and glucose metabolism revealed by its specific antagonist tetrabenazine.
    Raffo A; Hancock K; Polito T; Xie Y; Andan G; Witkowski P; Hardy M; Barba P; Ferrara C; Maffei A; Freeby M; Goland R; Leibel RL; Sweet IR; Harris PE
    J Endocrinol; 2008 Jul; 198(1):41-9. PubMed ID: 18577569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. VNUT and VMAT2 segregate within sympathetic varicosities and localize near preferred Cav2 isoforms in the rat tail artery.
    Mojard Kalkhoran S; Chow SHJ; Walia JS; Gershome C; Saraev N; Kim B; Poburko D
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H89-H105. PubMed ID: 30311774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.